comparemela.com

Latest Breaking News On - Wedbush pacgrow healthcare conference - Page 1 : comparemela.com

Y-mAbs to Participate at Upcoming Investor Conferences

Y-mAbs to Participate at Upcoming Investor Conferences
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkCanaccord genuityCourtney duganBo kruseY mabs therapeutics incY mabs therapeuticsInterim chief executive officerChief financial officerWedbush pacgrow healthcare conferenceAnnual growth conferencePrivate securities litigation reform actAnnual reportQuarterly report

Clearside Biomedical, Inc (NASDAQ:CLSD) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Clearside Biomedical First Quarter 2023 Financial Results and Corporate Update Call.

Peter changJenny kobinBausch lombTom chulaJonathan wollebenArshad khananiCharlie deignanSerge belangerCharles deignanYi chenDennis marcusGeorge lasezkaySuprachoroidal microinjectorAsia pacificLejla vajzovicAnnabel samimy

Elevation Oncology to Participate at the Wedbush PacGrow Healthcare Conference

/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for.

Shawnm lelandPrnewswire elevation oncology incCompany investor relationsElevation oncology incCorporate communications investor relationsChief executive officerElevation oncologyWedbush pacgrow healthcare conferenceInvestor relationsOncology investorCorporate communications

Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesSan diegoJulia deutschKimberly blackwellAlexandra royZentalis pharmaceuticals incZentalis pharmaceuticalsZentera therapeutics ltdChief executive officerTargeted oncologyWedbush pacgrow healthcare conferenceZentera therapeuticsGlobe newswire

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 02, 2022 Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate.

United statesCanaccord genuityRobert uhlExchange commissionHarpoon therapeutics incWedbush pacgrow healthcare conferenceAnnual growth conferenceHarpoon therapeuticsActivating constructPrivate securities litigation reform actHarpoon therapeutic

vimarsana © 2020. All Rights Reserved.